Update: Affibody Molecules for Molecular Imaging and Therapy for Cancer
作者： Anna Orlova , Joachim Feldwisch , Lars Abrahmsén , Vladimir Tolmachev
关键词:
摘要: … Affibody molecules are scaffold proteins, having a common frame of amino acids … of affinity ligands. The origin of Affibody molecules is the domain B of Staphylococcus aureus protein A. …
liebertonline.com参考文章(54)
Trastuzumab and breast cancer. The New England Journal of Medicine. ,vol. 345, pp. 995- 996 ,(2001) , 10.1056/NEJM200109273451312
Vladimir Tolmachev, L. Einarsson, Anna Orlova, Daniel Rosik, Mattias Sandström, Hans Lundqvist, Evaluation of [(111/114m)In]CHX-A''-DTPA-ZHER2:342, an affibody ligand coniugate for targeting of HER2-expressing malignant tumors. Quarterly Journal of Nuclear Medicine and Molecular Imaging. ,vol. 51, pp. 314- 323 ,(2007)
Marco Chinol, Helmut R Maecke, Lisa Bodei, Dik J Kwekkeboom, Eric P Krenning, Larry K Kvols, Giovanni Paganelli, Stanislas Pauwels, Lowell B Anthony, Thomas M. O'Dorisio, Roelf Valkema, Jan Mueller-Brand, Overview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin Analogs The Journal of Nuclear Medicine. ,vol. 46, ,(2005)
Caroline Grönwall, Andreas Jonsson, Sara Lindström, Elin Gunneriusson, Stefan Ståhl, Nina Herne, Selection and characterization of Affibody ligands binding to Alzheimer amyloid β peptides Journal of Biotechnology. ,vol. 128, pp. 162- 183 ,(2007) , 10.1016/J.JBIOTEC.2006.09.013
Eskender Mume, Anna Orlova, Barbro Larsson, Ann-Sofie Nilsson, Fredrik Y. Nilsson, Stefan Sjöberg, Vladimir Tolmachev, Evaluation of ((4-Hydroxyphenyl)ethyl)maleimide for Site-Specific Radiobromination of Anti-HER2 Affibody Bioconjugate Chemistry. ,vol. 16, pp. 1547- 1555 ,(2005) , 10.1021/BC050056O
Torun Engfeldt, Anna Orlova, Thuy Tran, Alexander Bruskin, Charles Widström, Amelie Eriksson Karlström, Vladimir Tolmachev, Imaging of HER2-expressing tumours using a synthetic Affibody molecule containing the 99mTc-chelating mercaptoacetyl-glycyl-glycyl-glycyl (MAG3) sequence European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 34, pp. 722- 733 ,(2007) , 10.1007/S00259-006-0266-4
Linda A. Landon, Susan L. Deutscher, Combinatorial discovery of tumor targeting peptides using phage display. Journal of Cellular Biochemistry. ,vol. 90, pp. 509- 517 ,(2003) , 10.1002/JCB.10634
Helena Wållberg, Anna Orlova, Slow Internalization of Anti-HER2 Synthetic Affibody Monomer 111In-DOTA-ZHER2:342-pep2 : Implications for Development of Labeled Tracers Cancer Biotherapy and Radiopharmaceuticals. ,vol. 23, pp. 435- 442 ,(2008) , 10.1089/CBR.2008.0464
Vladimir Tolmachev, Anna Orlova, Rikard Pehrson, Joakim Galli, Barbro Baastrup, Karl Andersson, Mattias Sandström, Daniel Rosik, Jörgen Carlsson, Hans Lundqvist, Anders Wennborg, Fredrik Y. Nilsson, Radionuclide Therapy of HER2-Positive Microxenografts Using a 177Lu-Labeled HER2-Specific Affibody Molecule Cancer Research. ,vol. 67, pp. 2773- 2782 ,(2007) , 10.1158/0008-5472.CAN-06-1630
Torun Engfeldt, Thuy Tran, Anna Orlova, Charles Widström, Joachim Feldwisch, Lars Abrahmsen, Anders Wennborg, Amelie Eriksson Karlström, Vladimir Tolmachev, 99mTc-chelator engineering to improve tumour targeting properties of a HER2-specific Affibody molecule European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 34, pp. 1843- 1853 ,(2007) , 10.1007/S00259-007-0474-6